Today's News | Note: News feeds may no longer be available for the articles on this page.

Obama gives powerful drug lobby a seat at healthcare table 6:08 AM 8/4/2009
Los Angeles Times
A popular president once criticized drug companies for greed now praises their work on behalf of the public good. ...

Pneumonia vaccine may help limit swine flu deaths 6:14 PM 8/3/2009
Los Angeles Times
Merck & Co's Pneumovax has the potential to prevent an estimated one-third of pneumonia deaths linked to swine flu. ...

Watson sees windfall as Toprol XL generic wins OK 5:04 PM 8/3/2009
Reuters
Watson Pharmaceuticals Inc said the US FDA approved its generic of popular blood pressure drug Toprol XL. Shipments of two rival generics were suspended due to manufacturing problems. ...

Amgen bone drug meets goal of late-stage study 3:37 PM 8/3/2009
Reuters
Amgen Inc's experimental osteoporosis drug denosumab met the primary goal of delaying time to fracture or other skeletal-related events in patients with advanced cancer. ...

Drug cuts diabetics' pancreatic cancer risk: study 3:30 PM 8/3/2009
Reuters
Diabetics that used metformin alone or in combination with other drugs had a reduced risk for pancreatic cancer. ...

Repros halts dosing of lead drug; seeks funding 8:38 AM 8/3/2009
Reuters
Repros Therapeutics suspended dosing patients in all clinical trials with its lead drug proellex. ...

Oncothyreon's cancer vaccine well-tolerated in long use 7:36 AM 8/3/2009
Reuters
Oncothyreon Inc's cancer vaccine Stimuvax was well-tolerated among patients with non-small cell lung cancer. No evidence of autoimmune reactions with prolonged use. ...

FDA lifts partial clinical hold on epilepsy drug:Icagen 6:57 AM 8/3/2009
Reuters
Icagen Inc said that US FDA lifted the partial clinical hold from its experimental epilepsy drug ICA-105665. The biopharmaceutical firm expects to complete a proof-of-concept study in patients with photosensitive epilepsy by mid 2010. ...

Shire's new Gaucher drug moves closer to market 4:20 AM 8/3/2009
Reuters
Shire Plc's new Gaucher disease drug velaglucerase alfa mo ved closer to market following positive Phase III trial results. ...

Sun Pharma, MedImmune Settle Lawsuit on Ethyol Drug 3:30 AM 8/3/2009
Bloomberg
Sun Pharmaceutical Industries settled a lawsuit with MedImmune Inc on a generic version of the cancer drug Ethyol. MedImmune granted Sun a license to patents. ...

Roche's Avastin gets US nod for kidney cancer drug 2:11 AM 8/3/2009
Reuters
Roche Holding's cancer drug Avastin has won approval from the US FDA for the treatment of metastatic renal cell carcinoma. ...

Savient says FDA declined to approve gout drug 4:08 PM 8/2/2009
Reuters
The US FDA declined to approve Savient Pharmaceuticals Inc's gout drug Krystexxa. The company seeks to resubmit its application to the FDA by early 2010. ...

MedImmune Ramps Up H1N1 Vaccine 5:28 AM 8/1/2009
Washington Post
AstraZeneca's MedImmune is producing more vaccine for the H1N1 flu virus than it originally predicted. The company expects to have more than 200 million doses by the end of 2009. MedImmune's flu vaccine is a nasal spray made with a live weakened virus. ...

AstraZeneca, Bristol-Myers diabetes drug wins US OK 12:25 PM 7/31/2009
Reuters
The US FDA is requiring a post-approval study to evaluate Onglyza's cardiovascular safety in higher-risk patients, but the drug was not linked to increased heart problems in low-risk diabetics, the FDA said. ...

Ambrilia to file for bankruptcy as cash dries up 10:33 AM 7/31/2009
Reuters
Canadian biotech company Ambrilia Biopharma Inc will file for bankruptcy in a Quebec court sparked by a dramatic stock decline. A 2006 licensing deal for its HIV/AIDS drug with Merck & Co was put on hold in July 2008. ...

<- Day Earlier | Today's News